BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2018 6:15:24 AM | Browse: 723 | Download: 718
 |
Received |
|
2018-03-11 07:10 |
|
Peer-Review Started |
|
2018-03-11 08:47 |
|
To Make the First Decision |
|
2018-03-30 06:01 |
|
Return for Revision |
|
2018-04-04 01:51 |
|
Revised |
|
2018-06-26 16:56 |
|
Second Decision |
|
2018-07-06 09:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-07-10 04:21 |
|
Articles in Press |
|
2018-07-10 04:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-07-14 20:06 |
|
Typeset the Manuscript |
|
2018-09-06 04:11 |
|
Publish the Manuscript Online |
|
2018-09-07 06:15 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fedaey Abbas, Mohsen El Kossi, Jon Jin Kim, Ajay Sharma and Ahmed Halawa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmed Halawa, FRCS (Gen Surg), FRSC, MD, MSc, Senior Lecturer, Surgeon, Department of Transplantation Surgery, Sheffield Teaching Hospitals, Herries Road, Sheffield S5 7AU, United Kingdom. ahmed.halawa@sth.nhs.uk |
| Key Words |
Kidney transplantation; De novo thrombotic microangiopathy; Thrombotic microangiopathy; Recurrent thrombotic microangiopathy; Atypical hemolytic uremic syndrome |
| Core Tip |
Many articles in the literature have covered either de novo or recurrent thrombotic microangiopathy (TMA) in an isolated manner; we tried here in this article to gather the criteria of both types in one review for comparison. Contrary to what was believed in the past, de novo TMA is more common and its prognosis is poorer. On the other hand, recurrent TMA relies on a wide base of genetic backgrounds, with mutation errors differing in their impact on disease behavior and consequently on allograft and patient survival. This base for instance is rapidly expanding, and ultimately warrants a parallel robust work up regimen. |
| Publish Date |
2018-09-07 06:15 |
| Citation |
Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplant 2018; 8(5): 122-141 |
| URL |
http://www.wjgnet.com/2220-3230/full/v8/i5/122.htm |
| DOI |
http://dx.doi.org/10.5500/wjt.v8.i5.122 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
